Quest Diagnostics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DGX and other ETFs, options, and stocks.

About DGX

Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. 

CEO
James E. Davis
CEOJames E. Davis
Employees
56,000
Employees56,000
Headquarters
Secaucus, New Jersey
HeadquartersSecaucus, New Jersey
Founded
1967
Founded1967
Employees
56,000
Employees56,000

DGX Key Statistics

Market cap
21.04B
Market cap21.04B
Price-Earnings ratio
21.73
Price-Earnings ratio21.73
Dividend yield
1.73%
Dividend yield1.73%
Average volume
974.07K
Average volume974.07K
High today
$189.80
High today$189.80
Low today
$185.13
Low today$185.13
Open price
$185.22
Open price$185.22
Volume
1.30M
Volume1.30M
52 Week high
$197.55
52 Week high$197.55
52 Week low
$157.20
52 Week low$157.20

Stock Snapshot

With a market cap of 21.04B, Quest Diagnostics(DGX) trades at $189.23. The stock has a price-to-earnings ratio of 21.73 and currently yields dividends of 1.7%.

During the trading session on 2026-02-05, Quest Diagnostics(DGX) shares reached a daily high of $189.80 and a low of $185.13. At a current price of $189.23, the stock is +2.2% higher than the low and still -0.3% under the high.

Trading activity shows a volume of 1.3M, compared to an average daily volume of 974.07K.

Over the past 52 weeks, Quest Diagnostics(DGX) stock has traded between a high of $197.55 and a low of $157.20.

Over the past 52 weeks, Quest Diagnostics(DGX) stock has traded between a high of $197.55 and a low of $157.20.

DGX News

Simply Wall St 1d
Quest Diagnostics Myeloma Blood Test Launch And What It May Mean For Valuation

Quest Diagnostics (NYSE:DGX) has launched a noninvasive blood test to measure residual disease in multiple myeloma patients. The test uses advanced flow cytome...

Quest Diagnostics Myeloma Blood Test Launch And What It May Mean For Valuation
Simply Wall St 3d
A Look At Quest Diagnostics Valuation After Barclays Upgrade And Earnings Growth Optimism

Barclays upgraded Quest Diagnostics (DGX) after expressing greater confidence in the company’s organic growth prospects, potential earnings outperformance, and...

A Look At Quest Diagnostics Valuation After Barclays Upgrade And Earnings Growth Optimism
TipRanks 6d
Barclays upgrades Quest Diagnostics on potential estimate upside

Barclays upgraded Quest Diagnostics (DGX) to Overweight from Equal Weight with a price target of $210, up from $195. The company has “laid to rest” fears about...

Analyst ratings

50%

of 22 ratings
Buy
45.5%
Hold
50%
Sell
4.5%

People also own

Based on the portfolios of people who own DGX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.